RPS6KB1 and psoriasis: Previous studies have highlighted activation of the mammalian target of rapamycin (mTOR)/S6K pathway in psoriasis lesions [80–83], although our findings suggest that mechanisms governing hyper-translation in psoriasis are broader, involving proteins besides the canonical mTOR targets (Fig. 2).